Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

Metformin Chemoprevention of Oral Premalignant Lesions

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT05536037
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-25T22:27:48.303679+00:00
Published At
2025-05-15T00:00:00+00:00
Record Updated At
2025-05-15
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Erythroplakia", "Leukoplakia", "Oral Cavity Carcinoma", "Proliferative Verrucous Leukoplakia"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2025-05-15"
protocolSection.identificationModule.nctId
"NCT05536037"
protocolSection.identificationModule.officialTitle
"Metformin Chemoprevention of Oral Premalignant Lesions"
protocolSection.statusModule.overallStatus
"TERMINATED"
protocolSection.designModule.phases
["PHASE1"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
""

Study condition terms

  • Erythroplakia (protocolSection.conditionsModule.conditions)
  • Leukoplakia (protocolSection.conditionsModule.conditions)
  • Oral Cavity Carcinoma (protocolSection.conditionsModule.conditions)
  • Proliferative Verrucous Leukoplakia (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.